Abstract
Intravascular iodinated contrast media administration continues to be a common cause of hospital acquired acute renal failure [1]. In the past decade our understanding of the pathogenesis of this association has led to improvement in our ability to prevent and manage this complication. In this review we have detailed the progress which has been made in this field in our department under the direction of Claude Jacobs.